Soluble neprilysin and long-term clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cohort study.

BMC Cardiovasc Disord · 2020 · PMC7409669 · PMID 32762650

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a marginal trendno p-value reported

The LVEF < 40% group had a trend of a higher rate of all-cause death in the neprilysin > 76.0 pg/ml group without a statistically significant interaction (HR 2.630, 95% CI 1.049–6.595, P for interaction = 0.150) and a marginal trend of a higher rate of MACE (HR 3.213, 95% CI 0.989–10.441, P for interaction = 0.083).

also in 626 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.